Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 1.000 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.595 | |
| 3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.593 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.579 | |
| 2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.576 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.575 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.574 | |
| 3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.565 | |
| 3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.564 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.561 | |
| 4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.553 | |
| 2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.534 | |
| 3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.533 | |
| 3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.525 | |
| 3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.524 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.522 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.520 | |
| 1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.519 | |
| 4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.519 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.510 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.510 | |
| 4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.508 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.507 | |
| 4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.507 | |
| 4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.507 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.506 | |
| 3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.504 | |
| 3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.502 | |
| 4bbe | 3O4 | Tyrosine-protein kinase JAK2 | / | 0.502 | |
| 4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.502 | |
| 1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.501 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.500 | |
| 3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.498 | |
| 3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.496 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.496 | |
| 4y93 | 746 | Tyrosine-protein kinase | / | 0.496 | |
| 4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.495 | |
| 3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.494 | |
| 3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.493 | |
| 3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.493 | |
| 2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.491 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.491 | |
| 2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.490 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.489 | |
| 4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.489 | |
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.487 | |
| 3lmg | ANP | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.486 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.485 | |
| 2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.483 | |
| 4cd0 | AWJ | ALK tyrosine kinase receptor | 2.7.10.1 | 0.483 | |
| 5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.483 | |
| 2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.482 | |
| 4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.481 | |
| 3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.480 | |
| 4bdg | P3J | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.479 | |
| 4c57 | FEF | Cyclin-G-associated kinase | 2.7.11.1 | 0.479 | |
| 4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.479 | |
| 3t8o | ATP | Rhodopsin kinase | / | 0.477 | |
| 4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.477 | |
| 4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.477 | |
| 1u54 | ACP | Activated CDC42 kinase 1 | / | 0.476 | |
| 2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.476 | |
| 4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.476 | |
| 4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.476 | |
| 2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.475 | |
| 1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.474 | |
| 2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.474 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.474 | |
| 4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.474 | |
| 4fsu | HK5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.474 | |
| 4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.474 | |
| 2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.473 | |
| 3oro | AGS | Serine/threonine protein kinase | / | 0.472 | |
| 4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.472 | |
| 2w05 | FRT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
| 4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.471 | |
| 2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.470 | |
| 2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.470 | |
| 4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.470 | |
| 5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.470 | |
| 1aq1 | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.469 | |
| 4g1w | G1W | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.469 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.469 | |
| 4y95 | 746 | Tyrosine-protein kinase | / | 0.469 | |
| 2zm1 | KSF | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.468 | |
| 4fk3 | 325 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.468 | |
| 2h96 | 893 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.467 | |
| 2wou | ZZF | TGF-beta receptor type-1 | 2.7.11.30 | 0.467 | |
| 2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.466 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.466 | |
| 2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.465 | |
| 2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.465 | |
| 2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.465 | |
| 3jy0 | LYG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.465 | |
| 3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.465 | |
| 4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.465 | |
| 4erw | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.465 | |
| 4riy | ANP | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.465 | |
| 2c0o | L2G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.464 | |
| 2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.464 | |
| 2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.464 | |
| 3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.464 | |
| 4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.464 | |
| 2fvd | LIA | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
| 2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.463 | |
| 2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.463 | |
| 5auw | QUE | Death-associated protein kinase 1 | 2.7.11.1 | 0.463 | |
| 2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.462 | |
| 2w7x | D1A | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.462 | |
| 2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
| 2z7q | ACP | Ribosomal protein S6 kinase alpha-1 | 2.7.11.1 | 0.462 | |
| 4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.462 | |
| 2vu3 | LZE | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
| 4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.461 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.460 | |
| 2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.460 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.460 | |
| 3nwx | KVS | Gag-Pol polyprotein | 3.4.23.16 | 0.460 | |
| 3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.460 | |
| 4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.460 | |
| 4jbq | VX6 | Aurora kinase A | 2.7.11.1 | 0.460 | |
| 2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.459 | |
| 4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.459 | |
| 4otw | DB8 | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.459 | |
| 5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.459 | |
| 2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.458 | |
| 3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.458 | |
| 4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.458 | |
| 4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.458 | |
| 1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.457 | |
| 3t11 | 3T1 | Gag-Pol polyprotein | 3.4.23.16 | 0.457 | |
| 3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.457 | |
| 2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.456 | |
| 2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.456 | |
| 3nwq | 2NC | Gag-Pol polyprotein | 3.4.23.16 | 0.456 | |
| 3v5j | 0F2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.456 | |
| 3v8t | 477 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.456 | |
| 4e73 | 0NR | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.456 | |
| 4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.456 | |
| 2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.455 | |
| 2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.455 | |
| 2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.455 | |
| 4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.455 | |
| 4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.455 | |
| 5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.455 | |
| 1iol | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.454 | |
| 2cdz | 23D | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.454 | |
| 2ycs | NXP | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.454 | |
| 3tkh | 07S | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
| 4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.454 | |
| 4jrv | KJV | Epidermal growth factor receptor | 2.7.10.1 | 0.454 | |
| 4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.454 | |
| 1wvx | BD4 | Death-associated protein kinase 1 | 2.7.11.1 | 0.453 | |
| 2eb3 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.453 | |
| 3ofm | 4B0 | Casein kinase II subunit alpha' | 2.7.11.1 | 0.453 | |
| 4a06 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.453 | |
| 4hjo | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.453 | |
| 4hyu | 1BK | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.453 | |
| 2wmq | ZYQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
| 2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.452 | |
| 3qk0 | QK0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.452 | |
| 2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.451 | |
| 3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.451 | |
| 3orm | AGS | Serine/threonine protein kinase | / | 0.451 | |
| 4ezj | 0SC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.451 | |
| 4wo5 | 324 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.451 | |
| 5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.451 | |
| 2yn8 | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.450 | |
| 3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.450 | |
| 3zly | YSO | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.450 | |
| 4fl3 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.450 | |
| 2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.449 | |
| 2x2l | X2L | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.449 | |
| 2zv9 | PP2 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.449 | |
| 3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.449 | |
| 3ma3 | 01I | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.449 | |
| 4w9w | YDJ | BMP-2-inducible protein kinase | 2.7.11.1 | 0.449 | |
| 5dr9 | SKE | Aurora kinase A | 2.7.11.1 | 0.449 | |
| 2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.448 | |
| 2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.448 | |
| 3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.448 | |
| 4anm | WUL | Casein kinase II subunit alpha | 2.7.11.1 | 0.448 | |
| 4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.448 | |
| 4gu9 | 4GU | Focal adhesion kinase 1 | 2.7.10.2 | 0.448 | |
| 4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 | 0.448 | |
| 4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.448 | |
| 3igo | ANP | Calmodulin-domain protein kinase 1, putative | / | 0.447 | |
| 3rkb | 12Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
| 3zep | 1NX | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.447 | |
| 4bi0 | Z0W | Dual specificity protein kinase TTK | 2.7.12.1 | 0.447 | |
| 4kik | KSA | Inhibitor of nuclear factor kappa-B kinase subunit beta | 2.7.11.10 | 0.447 | |
| 1py5 | PY1 | TGF-beta receptor type-1 | 2.7.11.30 | 0.446 | |
| 3ckx | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.446 | |
| 4m69 | ANP | Receptor-interacting serine/threonine-protein kinase 3 | 2.7.11.1 | 0.446 | |
| 4o0u | ADN | Aurora kinase A | 2.7.11.1 | 0.446 | |
| 4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.446 | |
| 1dkf | BMS | Retinoic acid receptor alpha | / | 0.445 | |
| 1q3w | ATU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.445 | |
| 2ghm | LIC | Mitogen-activated protein kinase 14 | / | 0.445 | |
| 2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
| 2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.445 | |
| 3r9d | X6B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
| 4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.445 | |
| 4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.445 | |
| 1rw8 | 580 | TGF-beta receptor type-1 | 2.7.11.30 | 0.444 | |
| 1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.444 | |
| 3ac5 | KZM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.444 | |
| 3axw | TID | Casein kinase II subunit alpha | 2.7.11.1 | 0.444 | |
| 4ftj | H8K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
| 4hvg | 19Q | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.444 | |
| 4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.444 | |
| 2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.443 | |
| 3hx4 | ANP | Calmodulin-domain protein kinase 1 | / | 0.443 | |
| 4c61 | LMM | Tyrosine-protein kinase JAK2 | / | 0.443 | |
| 6cp4 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.443 | |
| 1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.442 | |
| 2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 2pvl | P55 | Casein kinase II subunit alpha | 2.7.11.1 | 0.442 | |
| 2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.442 | |
| 3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.442 | |
| 4c4g | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.442 | |
| 4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.442 | |
| 4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.442 | |
| 4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.442 | |
| 5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.442 | |
| 1oec | AA2 | Fibroblast growth factor receptor 2 | / | 0.441 | |
| 2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.441 | |
| 2wms | ZYS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
| 2yiq | YIQ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.441 | |
| 3eb0 | DRK | Uncharacterized protein | / | 0.441 | |
| 3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.441 | |
| 3uvp | 048 | Mitogen-activated protein kinase 14 | / | 0.441 | |
| 4dk5 | 0KO | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.441 | |
| 4jbp | YPH | Aurora kinase A | 2.7.11.1 | 0.441 | |
| 5aux | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.441 | |
| 3uzc | T4E | Adenosine receptor A2a | / | 0.441 | |
| 2wqe | ADP | Aurora kinase A | 2.7.11.1 | 0.440 | |
| 3a7h | ATP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.440 | |
| 3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.440 | |
| 3ggf | GVD | Serine/threonine-protein kinase 26 | / | 0.440 | |
| 3gu6 | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.440 | |
| 4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 4nj3 | 2KD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 |